Discover
SPRO
Spero Therapeutics, Inc.
1.06
2 x 1.07
1 x 1.07
bid
ask
-
0.05
4.50%
2 @ 05:47 PM
1.08 +0.02 (1.84%)
| Ytd | -54.51% | |
| 1y | -55.08% |
1.05
day range
1.11
1.04
52 week range
3.08
| Open | 1.11 | Prev Close | 1.11 | Low | 1.05 | High | 1.11 | Mkt Cap | 61.73M |
| Vol | 309.87K | Avg Vol | 608.55K | EPS | 0.14 | P/E | 7.57 | Forward P/E | -0.83 |
| Beta | 0.63 | Short Ratio | 2.08 | Inst. Own | 23.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.18 | 200-d Avg | 1.99 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 9.93M | ||
| Research and Development Expense | 3.43M | ||
| Selling, General and Administrative Expense | 6.49M | ||
| Operating Income | -9.93M | ||
| Net Income | -9.55M | ||
| Net Income Common Stock | -9.55M | ||
| Net Income Common Stock (USD) | -9.55M | ||
| Consolidated Income | -9.55M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -9.55M | ||
| Earning Before Interest & Taxes (USD) | -9.55M | ||
| Weighted Average Shares | 57.97M | ||
| Weighted Average Shares Diluted | 57.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 50.77M | ||
| Cash and Equivalents (USD) | 50.77M | ||
| Trade and Non-Trade Receivables | 25.00K | ||
| Current Assets | 51.58M | ||
| Property, Plant & Equipment Net | 1.03M | ||
| Total Assets | 52.77M | ||
| Debt Current | 2.00M | ||
| Total Debt | 2.04M | ||
| Current Liabilities | 8.43M | ||
| Debt Non-Current | 43.00K | ||
| Total Liabilities | 8.56M | ||
| Accumulated Retained Earnings (Deficit) | -467.82M | ||
| Shareholders Equity | 44.20M | ||
| Shareholders Equity (USD) | 44.20M | ||
| Assets Non-Current | 1.18M | ||
| Total Debt (USD) | 2.04M | ||
| Liabilities Non-Current | 134.00K | ||
| Trade and Non-Trade Payables | 155.00K | ||
| Tax Liabilities | 163.00K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.35M | ||
| Net Cash Flow from Operations | -5.35M | ||
| Share Based Compensation | 822.00K | ||